机构:[1]Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China外科中心胸外科中心四川省肿瘤医院[2]Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China四川省肿瘤医院[3]Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China外科中心胸外科中心四川省肿瘤医院
出处:
ISSN:
基金:
National Key Research and Development Program; Science and Technology Department of Sichuan Province [2020YFH0169]; Wu Jieping Medical Research Project [320.6750.2020-15-3]; Sichuan Province Clinical Key Specialty Construction Project; Japan-China Sasakawa Medical Fellowship [85]
第一作者机构:[1]Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
通讯作者:
通讯机构:[3]Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
推荐引用方式(GB/T 7714):
Zhou Qiang,He Qiao,Han Yongtao,et al.The role of folate receptor-positive circulating tumor cells in the prognosis analysis of esophageal squamous cell carcinomas[J].JOURNAL OF CLINICAL ONCOLOGY.2024,42(16):
APA:
Zhou, Qiang,He, Qiao,Han, Yongtao,Wang, Dongsheng&Leng, Xuefeng.(2024).The role of folate receptor-positive circulating tumor cells in the prognosis analysis of esophageal squamous cell carcinomas.JOURNAL OF CLINICAL ONCOLOGY,42,(16)
MLA:
Zhou, Qiang,et al."The role of folate receptor-positive circulating tumor cells in the prognosis analysis of esophageal squamous cell carcinomas".JOURNAL OF CLINICAL ONCOLOGY 42..16(2024)